Markets
| Security ▼ | Price | % | Buy | Sell | Target price | Potential |
|---|---|---|---|---|---|---|
| Vivani Medical Inc. |
€1.15
12.12.25 |
-6.500% | 6 | 1 | €3.60 | 212.765% |
| Vitrolife AB |
€12.71
12.12.25 |
-0.310% | 0 | 0 | - | - |
| Vita 34 AG |
€6.70
12.12.25 |
15.250% | 0 | 0 | - | - |
| Visiomed Group |
€0.21
12.12.25 |
-1.170% | 0 | 0 | - | - |
| Visiodent S.a.inh. |
€2.94
19.01.22 |
- | 0 | 0 | - | - |
| Virtus Health Ltd |
€5.45
04.08.22 |
- | 0 | 0 | - | - |
| Virbac S.A. |
€335.50
11.12.25 |
-0.300% | 0 | 0 | - | - |
| Viracta Therapeutics Inc. |
€0.008
08.05.25 |
- | 0 | 0 | - | - |
| Viking Therapeutics Inc |
€31.57
12.12.25 |
1.330% | 5 | 0 | - | - |
| ViewRay Inc |
€0.025
03.08.23 |
2400.000% | 0 | 0 | - | - |
| Vical Inc. |
€0.63
02.09.19 |
5.300% | 0 | 0 | - | - |
| Viatris Inc. |
€9.93
12.12.25 |
0.360% | 0 | 0 | - | - |
| Vetoquinol |
€75.40
11.12.25 |
-0.920% | 0 | 0 | - | - |
| Vertex Pharmaceuticals Inc. |
€385.20
12.12.25 |
1.110% | 43 | 0 | €464.40 | 20.561% |
| Vericel Corp. |
€31.60
12.12.25 |
0.000% | 0 | 0 | - | - |
| Verastem Inc. |
€8.20
12.12.25 |
1.860% | 19 | 1 | €12.69 | 54.785% |
| Veracyte Inc. |
€35.60
12.12.25 |
-2.200% | 0 | 0 | - | - |
| Venture Life Group plc |
€0.69
11.12.25 |
- | 0 | 0 | - | - |
| Veloxis Pharmaceuticals As |
€0.79
24.02.20 |
- | 0 | 0 | - | - |
| Veeva Systems A |
€190.15
12.12.25 |
-2.530% | 2 | 0 | - | - |
| Vectura plc |
€1.95
04.02.22 |
- | 0 | 0 | - | - |
| VBI Vaccines Inc. |
€0.085
07.08.24 |
113.920% | 0 | 0 | - | - |
| Vaxart Inc. |
€0.28
12.12.25 |
-0.710% | 2 | 0 | - | - |
| Varian Medical Systems Inc. |
€148.60
24.07.21 |
- | 0 | 0 | - | - |
| Varex Imaging Corp |
€9.95
12.12.25 |
1.530% | 0 | 0 | - | - |
| Vanda Pharmaceuticals |
€5.35
12.12.25 |
-5.310% | 13 | 0 | €17.30 | 223.394% |
| Valneva SE |
€3.76
12.12.25 |
-2.240% | 5 | 0 | €5.00 | 32.908% |
| ValiRx plc |
€0.001
11.12.25 |
- | 0 | 0 | - | - |
| Valbiotis |
€0.66
11.12.25 |
-4.230% | 0 | 0 | - | - |
| Utah Medical Products Inc |
€47.00
11.12.25 |
0.860% | 0 | 0 | - | - |

